You are here
AFASCI INC
UEI: UGMEBNM4WSL6
# of Employees: 10
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Development of a Next Generation Visual Performance Assessment System for Rodents
Amount: $1,480,057.007. PROJECT SUMMARY Title: Development of a Next Generation Visual Performance Assessment System for Rodents Visual behavior abnormalities not only link directly to the retinal pathology and visual pat ...
SBIRPhase II2019Department of Health and Human Services National Institutes of Health -
IND-enabling studies on novel Cav3 T-channel modulators for treatment of neuropathic pain
Amount: $2,983,561.007. PROJECT SUMMARY Neuropathic pain remains a poorly managed medical condition affecting more than 1.5 billion people worldwide. Over 20 million people suffered from diabetic neuropathy and neuropathi ...
SBIRPhase II2018Department of Health and Human Services National Institutes of Health -
Discovering GIRK Channel Direct Activator as a Novel Chronic Insomnia Therapeutic
Amount: $399,429.00PROJECT SUMMARY Millions of Americans suffer from sleep disturbances among which insomnia is the most commonInsomnia is often poorly treated with current pharmacotherapies and we propose to develop a ...
SBIRPhase I2018Department of Health and Human Services National Institutes of Health -
Development of patented tricyclic pyrones molecules for the treatment of Alzheimer's Disease
Amount: $2,174,709.00Project Summary Abstract Alzheimer s diseaseADafflicts approximatelymillion people worldwide and is the most common cause of dementia in the elderlyThere is an unmet medical need for the development o ...
SBIRPhase II2017Department of Health and Human Services National Institutes of Health -
Developing a novel CGRP antagonist for treatment of dental neuroinflammatory pain
Amount: $221,872.00DESCRIPTION provided by applicant Management of pain and inflammation is the most critical aspect of dental practice Inadequate pain control affects patients in many ways beyond the treatment and ...
SBIRPhase I2016Department of Health and Human Services National Institutes of Health -
Sample-free onsite detection of cocaine using microneedles via laser-treated skin
Amount: $223,633.00DESCRIPTION provided by applicant The abuse of illicit drugs such as cocaine marijuana and heroin remains a critical public health concern throughout the country and is associated with staggering ...
STTRPhase I2016Department of Health and Human Services National Institutes of Health -
A Visual Assessment System for Retinal Function/Drug Discovery
Amount: $233,235.00DESCRIPTION provided by applicant Preclinical evaluation of treatment strategies for retinal neurodegenerative diseases is highly dependent on mouse models Classical methods to assess the visual f ...
STTRPhase I2015Department of Health and Human Services National Institutes of Health -
Development of selective Cav3 channel blockers for treatment of neuropathic pain
Amount: $1,432,207.00DESCRIPTION provided by applicant Millions of Americans suffer from chronic neuropathic pain which is often refractory to current treatment In search of a solution to this problem of chronic u ...
SBIRPhase II2015Department of Health and Human Services National Institutes of Health -
Development of selective Cav3 channel blockers for treatment of neuropathic pain
Amount: $1,657,206.00DESCRIPTION (provided by applicant): Millions of Americans suffer from chronic neuropathic pain, which is often refractory to current treatment. In search of a solution to this problem of chronic, u ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
Development of an automated noninvasive system for sleep restriction in rodents
Amount: $852,597.00DESCRIPTION (provided by applicant): Sleep deprivation (SD) occurs universally in modern societies and causes significant social and financial harm. Numerous human and animal studies indicate that var ...
STTRPhase II2013Department of Health and Human Services National Institutes of Health
